SeqLL Inc. (SQL)
6.60
-0.16 (-2.37%)
At close: Jan 16, 2025, 9:00 PM
-2.37% (1D)
| Bid | n/a |
| Market Cap | 2.51M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -4.33M |
| EPS (ttm) | -16.4 |
| PE Ratio (ttm) | -0.4023841463414634 |
| Forward PE | n/a |
| Analyst | n/a |
| Ask | n/a |
| Volume | 19,321 |
| Avg. Volume (20D) | 0 |
| Open | 8.20 |
| Previous Close | 6.76 |
| Day's Range | 6.60 - 8.20 |
| 52-Week Range | 6.60 - 8.20 |
| Beta | 1.29 |
About SQL
SeqLL Inc. operates as a life sciences instrumentation and research services company worldwide. The company designs, develops, and manufactures genetic analysis technologies. It offers true single molecule sequencing (tSMS) platform, which offers a single molecule solution for DNA and RNA sequencing. The company has a collaboration agreement with Bernstein Laboratory, Ting Laboratory, The Jackson Laboratory for Genomic Medicine, Weizmann Institut...
Industry Medical - Diagnostics & Research
Sector Healthcare
IPO Date Aug 27, 2021
Employees 7
Stock Exchange NASDAQ
Ticker Symbol SQL
Website https://seqll.com